Reported Consolidated quarterly numbers for Ajanta Pharma are:Net Sales at Rs 1,054.08 crore in March 2024 up 19.53% from Rs. 881.84 crore in March 2023.
Quarterly Net Profit at Rs. 202.72 crore in March 2024 up 65.82% from Rs. 122.25 crore in March 2023.
EBITDA stands at Rs. 313.82 crore in March 2024 up 68.54% from Rs. 186.20 crore in March 2023.
Ajanta Pharma EPS has increased to Rs. 16.10 in March 2024 from Rs. 9.54 in March 2023.
| Ajanta Pharma shares closed at 2,383.85 on May 03, 2024 (NSE) and has given 30.36% returns over the last 6 months and 84.34% over the last 12 months. |
| Ajanta Pharma | | Consolidated Quarterly Results | in Rs. Cr. |
|
| Mar'24 | Dec'23 | Mar'23 | | Net Sales/Income from operations | 1,054.08 | 1,105.15 | 881.84 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 1,054.08 | 1,105.15 | 881.84 | | EXPENDITURE | | Consumption of Raw Materials | 259.03 | 239.05 | 231.90 | | Purchase of Traded Goods | 40.44 | 39.29 | 29.27 | | Increase/Decrease in Stocks | -35.09 | 15.83 | -20.27 | | Power & Fuel | -- | -- | -- | | Employees Cost | 233.51 | 231.35 | 223.64 | | Depreciation | 34.25 | 34.26 | 33.02 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 277.87 | 265.56 | 267.93 | | P/L Before Other Inc., Int., Excpt. Items & Tax | 244.07 | 279.81 | 116.35 | | Other Income | 35.50 | 13.59 | 36.83 | | P/L Before Int., Excpt. Items & Tax | 279.57 | 293.40 | 153.18 | | Interest | 1.53 | 2.49 | 1.13 | | P/L Before Exceptional Items & Tax | 278.04 | 290.91 | 152.05 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 278.04 | 290.91 | 152.05 | | Tax | 75.32 | 80.88 | 29.80 | | P/L After Tax from Ordinary Activities | 202.72 | 210.03 | 122.25 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 202.72 | 210.03 | 122.25 | | Minority Interest | -- | -- | -- | | Share Of P/L Of Associates | -- | -- | -- | | Net P/L After M.I & Associates | 202.72 | 210.03 | 122.25 | | Equity Share Capital | 25.27 | 25.27 | 25.27 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 16.10 | 16.68 | 9.54 | | Diluted EPS | 16.09 | 16.67 | 9.54 | | EPS After Extra Ordinary | | Basic EPS | 16.10 | 16.68 | 9.54 | | Diluted EPS | 16.09 | 16.67 | 9.54 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
